olprinone has been researched along with Hypoxia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamamoto, H | 1 |
| Miyabe, M; Tajima, K; Takahashi, H; Toyooka, H | 1 |
| Ai, K; Kosugi, S; Kotake, Y; Morisaki, H; Satoh, T; Serita, R; Takeda, J; Yamamoto, M | 1 |
| Amitani, S; Kakura, H; Koga, M; Misumi, K; Miura, N; Miyahara, K; Sakamoto, H; Sohara, H | 1 |
4 other study(ies) available for olprinone and Hypoxia
| Article | Year |
|---|---|
[The effect of PDEIII inhibitors and colforsin daropate on hypoxic pulmonary vasoconstriction in rabbit lungs].
Topics: Animals; Colforsin; Hypoxia; Imidazoles; In Vitro Techniques; Male; Milrinone; Phosphodiesterase Inhibitors; Pulmonary Circulation; Pyridones; Rabbits; Vasoconstriction | 2008 |
Olprinone, a phosphodiesterase III inhibitor, does not affect hypoxia-induced pial arteriolar dilatation in rabbits.
Topics: Animals; Arterioles; Blood Gas Analysis; Blood Pressure; Cerebrovascular Circulation; Heart Rate; Hypoxia; Imidazoles; Male; Phosphodiesterase Inhibitors; Pyridones; Rabbits; Vasodilation | 2003 |
Olprinone, a phosphodiesterase III inhibitor, reduces gut mucosal injury and portal endotoxin level during acute hypoxia in rabbits.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Carbon Dioxide; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Progression; Dose-Response Relationship, Drug; Endotoxins; Hydrogen-Ion Concentration; Hypoxia; Imidazoles; Intestinal Mucosa; Male; Organ Size; Oxygen Consumption; Phosphodiesterase Inhibitors; Portal Vein; Pyridones; Rabbits; Splanchnic Circulation | 2003 |
Hemodynamic effects of intravenous administration of olprinone hydrochloride on experimental pulmonary hypertension.
Topics: Animals; Blood Gas Analysis; Cardiac Output; Cardiotonic Agents; Dogs; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Imidazoles; Injections, Intravenous; Pulmonary Circulation; Pyridones; Stroke Volume; Vascular Resistance; Ventricular Function, Right | 2000 |